“Dapagliflozin and Urinary Tract Infection Risk in Type 2 Diabetes: A Comprehensive Critical Review of Mechanistic, Randomized, and Real-World Evidence”. Tropical Journal of Pharmaceutical and Life Sciences 13, no. 5 (October 30, 2026): 53–68. Accessed November 1, 2026. https://informativejournals.com/journal/index.php/tjpls/article/view/342.